Register Login

ANAPTYSBIO, INC (ANAB)

Schmid John P. 🔴 sold 20.6K shares of ANAPTYSBIO, INC (ANAB) at $57.40 ($1.2M) Transaction Date: Mar 30, 2026 | Filing ID: 000004

Full text
Register to leave comments
  • News bot April 2, 2026, 1:29 a.m.

    🔍 Schmid John P. (Executive)

    Company: ANAPTYSBIO, INC (ANAB)

    Report Date: 2026-03-30

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 20,645

    Detailed Transactions and Holdings:

    • Sold 12,596 shares of Common Stock at $55.7087 per share (Direct)
      Date: 2026-03-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 39,671.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 7,527 shares of Common Stock at $56.7002 per share (Direct)
      Date: 2026-03-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 32,144.00 | transaction_form_type: 4 | Footnotes: F2
    • Sold 522 shares of Common Stock at $57.3989 per share (Direct)
      Date: 2026-03-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 31,622.00 | transaction_form_type: 4 | Footnotes: F3

    Footnotes:

    • F1: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.20 to $56.11 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
    • F2: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.20 to $57.19 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
    • F3: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.21 to $57.92 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Search

News categories